“Mass Effect: New Earth, A 4D Holographic Journey” opens to the public today and features Near/Far Acoustic Field (NFAF), an audio infrastructure developed by researchers based at the Qualcomm Institute.
While investigating a potential therapeutic target for the ERK1 and 2 pathway, a widely expressed signaling molecule known to drive cancer growth in one third of patients with colorectal cancer, University of California San Diego School of Medicine researchers found that an alternative pathway immediately emerges when ERK1/2 is halted, thus allowing tumor cell proliferation to continue.
Injections of the soil bacterium Mycobacterium vaccae promote stress resilience and improve coping behaviors in mice, according to a new study led by researchers at University of California San Diego School of Medicine and University of Colorado Boulder. The researchers also found that
Researchers at the Kavli Institute for Brain and Mind at UC San Diego have developed a technique for imaging brain activity in a freely walking fruit fly. Working with one of the most common model organisms in science, the team shows for the first time what goes on in the brain of the fly during courtship – when it’s unrestrained.
On May 13, the White House Office of Science and Technology Policy (OSTP) announced a new National Microbiome Initiative, a coordinated effort to better understand microbiomes and to develop tools to protect and restore healthy microbiome function. OSTP is launching the initiative with a combined federal agency investment of more than $121 million. The University of California San Diego is a key participant in this effort, investing $12 million in its own microbiome research efforts.
A diabetes medication described in some studies as an effective treatment for nonalcoholic fatty liver disease (NAFLD) works no better than a placebo, report researchers at University of California San Diego School of Medicine, after conducting the first randomized, double-blind, controlled clinical trial of sitagliptin, an oral antihyperglycemic marketed by Merck & Co. under the name Januvia.
Keep up with all the latest from UC San Diego. Subscribe to the newsletter today.
